DEXVETRA
Live / Allowed — First extension granted (statement of use) (as of 04 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99432256
- Mark type
- Word mark
- Filed
- 08 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Kathryn Starshak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary hypotonic preparations, including injectable preparations, namely, sedative and analgesic medications; pharmaceutical and veterinary preparations, including injectable preparations, to induce sedation and anaesthesia; pre-filled vials and pre-filled injectables in the nature of syringes, intravenous bags and cartridges containing medical and veterinary preparations, namely, sedative and analgesic medications; pre-filled vials and pre-filled injectables in the nature of syringes, intravenous bags and cartridges containing dexmedetomidine
Owner
- Parnell Technologies Pty Ltd, ALEXANDRIA, AU
- Parnell Technologies Pty Ltd, ALEXANDRIA, AU
Prosecution history
- 05 Nov 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2026 — SOU EXTENSION 1 GRANTED
- 04 Nov 2026 — SOU EXTENSION 1 FILED
- 04 Nov 2026 — SOU TEAS EXTENSION RECEIVED
- 19 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 02 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Mar 2026 — NON-FINAL ACTION E-MAILED